Three suspected cases of sugammadex-induced anaphylactic shock

BMC Anesthesiology

Volumn 14, Issue 1, 2014, Pages 1-5

  Takazawa, Tomonori ^a   Tomita, Yukinari ^b   Yoshida, Nagahide ^c   Tomioka, Akihiro ^d   Horiuchi, Tatsuo ^a   Nagata, Chie ^a   Orihara, Masaki ^a   Yamada, Makiko Hardy ^a   Saito, Shigeru ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Isesaki Municipal Hospital   (Japan)

^c SAISEIKAI MAEBASHI HOSPITAL   (Japan)

^d Gunma Chuo General Hospital   (Japan)

Author keywords

Anaphylactic shock; General anesthesia; Sugammadex

Indexed keywords

AMINOPHYLLINE; ATROPINE; CHLORPHENIRAMINE MALEATE; EPHEDRINE; EPINEPHRINE; FLURBIPROFEN AXETIL; HYDROCORTISONE; PENTAZOCINE; PHENYLEPHRINE; PROPOFOL; RANITIDINE; REMIFENTANIL; ROCURONIUM; SEVOFLURANE; SUGAMMADEX;

ADOLESCENT; ADVERSE DRUG REACTION; AGED; ALLERGIC REACTION; ALLERGY TEST; ANAPHYLAXIS; ANESTHESIOLOGICAL PROCEDURE; APPENDECTOMY; ARTICLE; BLOOD GAS ANALYSIS; BRONCHITIS; CASE REPORT; CONSCIOUSNESS LEVEL; DEPRESSED BLOOD PRESSURE; DRUG DOSE INCREASE; ENDOTRACHEAL INTUBATION; ERYTHEMA; EXTUBATION; FEMALE; GENERAL ANESTHESIA; HOSPITAL DISCHARGE; HUMAN; HYPERCAPNIA; KNEE ARTHROPLASTY; LAPAROSCOPY; MALE; NEUROMUSCULAR BLOCKING; OPERATION DURATION; OXYGEN SATURATION; PANSINECTOMY; PRICK TEST; SINOBRONCHITIS; SURGICAL TECHNIQUE; TACHYCARDIA; TREATMENT RESPONSE;

EID: 84988884431     PISSN: None     EISSN: 14712253     Source Type: Journal    
DOI: 10.1186/1471-2253-14-92     Document Type: Article

References (19)

1. Paton F, Paulden M, Chambers D, Heirs M, Duffy S, Hunter JM, Sculpher M, Woolacott N: Sugammadex compared with neostigmine/glycopyrrolate for routine reversal of neuromuscular block: a systematic review and economic evaluation. Br J Anaesth 2010, 105(5):558-567.
2. Cammu G, De Kam PJ, Demeyer I, Decoopman M, Peeters PA, Smeets JM, Foubert L: Safety and tolerability of single intravenous doses of sugammadex administered simultaneously with rocuronium or vecuronium in healthy volunteers. Br J Anaesth 2008, 100(3):373-379.
3. Godai K, Hasegawa-Moriyama M, Kuniyoshi T, Kakoi T, Ikoma K, Isowaki S, Matsunaga A, Kanmura Y: Three cases of suspected sugammadex-induced hypersensitivity reactions. Br J Anaesth 2012, 109(2):216-218.
4. Menendez-Ozcoidi L, Ortiz-Gomez JR, Olaguibel-Ribero JM, Salvador-Bravo MJ: Allergy to low dose sugammadex. Anaesthesia 2011, 66(3):217-219.
5. Motoyama Y, Izuta S, Maekawa N, Chuma R: [Case of anaphylactic reaction caused by sugammadex]. Masui 2012, 61(7):746-748.
6. Peeters PA, van den Heuvel MW, van Heumen E, Passier PC, Smeets JM, van Iersel T, Zwiers A: Safety, tolerability and pharmacokinetics of sugammadex using single high doses (up to 96 mg/kg) in healthy adult subjects: a randomized, double-blind, crossover, placebo-controlled, single-centre study. Clin Drug Investig 2010, 30(12):867-874.
7. Sadleir PH, Russell T, Clarke RC, Maycock E, Platt PR: Intraoperative anaphylaxis to sugammadex and a protocol for intradermal skin testing. Anaes Inten Care 2014, 42(1):93-96.
8. Jeyadoss J, Kuruppu P, Nanjappa N, Van Wijk R: Sugammadex hypersensitivity-a case of anaphylaxis. Anaes Intens Care 2014, 42(1):89-92.
9. Dewachter P, Mouton-Faivre C, Emala CW: Anaphylaxis and anesthesia: controversies and new insights. Anesthesiology 2009, 111(5):1141-1150.
10. Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A, Brown SG, Camargo CA Jr, Cydulka R, Galli SJ, Gidudu J, Gruchalla RS, Harlor AD Jr, Hepner DL, Lewis LM, Lieberman PL, Metcalfe DD, O'Connor R, Muraro A, Rudman A, Schmitt C, Scherrer D, Simons FE, Thomas S, Wood JP, Decker WW: Second symposium on the definition and management of anaphylaxis: summary report-Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 2006, 117(2):391-397.
11. Harper NJ, Dixon T, Dugue P, Edgar DM, Fay A, Gooi HC, Herriot R, Hopkins P, Hunter JM, Mirakian R, Pumphrey RS, Seneviratne SL, Walls AF, Williams P, Wildsmith JA, Wood P, Nasser AS, Powell RK, Mirakhur R, Soar J: Suspected anaphylactic reactions associated with anaesthesia. Anaesthesia 2009, 64(2):199-211.
12. Mertes PM, Laxenaire MC, Alla F, Groupe d'Etudes des Reactions Anaphylactoides P: Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000. Anesthesiology 2003, 99(3):536-545.
13. Dewachter P, Mouton-Faivre C: What investigation after an anaphylactic reaction during anaesthesia? Curr Opin Anesthesio 2008, 21(3):363-368.
14. Fisher M, Baldo BA: Anaphylaxis during anaesthesia: current aspects of diagnosis and prevention. Eur J Anaesthesiol 1994, 11(4):263-284.
15. Clarke RC, Sadleir PH, Platt PR: The role of sugammadex in the development and modification of an allergic response to rocuronium: evidence from a cutaneous model. Anaesthesia 2012, 67(3):266-273.
16. Ewan PW, Dugue P, Mirakian R, Dixon TA, Harper JN, Nasser SM, Bsaci: BSACI guidelines for the investigation of suspected anaphylaxis during general anaesthesia. Clin Exper allergy 2010, 40(1):15-31.
17. Kroigaard M, Garvey LH, Gillberg L, Johansson SG, Mosbech H, Florvaag E, Harboe T, Eriksson LI, Dahlgren G, Seeman-Lodding H, Takala R, Wattwil M, Hirlekar G, Dahlén B, Guttormsen AB: Scandinavian Clinical Practice Guidelines on the diagnosis, management and follow-up of anaphylaxis during anaesthesia. Acta anaesthesiologica Scandinavica 2007, 51(6):655-670.
18. Kotake Y, Ochiai R, Suzuki T, Ogawa S, Takagi S, Ozaki M, Nakatsuka I, Takeda J: Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block. Anesth Analg 2013, 117(2):345-351.
19. Mertes PM, Malinovsky JM, Jouffroy L, Working Group of the S, Sfa, Aberer W, Terreehorst I, Brockow K, Demoly P, ENDA; EAACI Interest Group on Drug Allergy: Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice. Journal Invest Allergology Clinical Immun 2011, 21(6):442-453.